Literature DB >> 26399452

The role of adult tissue-derived stem cells in chronic leg ulcers: a systematic review focused on tissue regeneration medicine.

Bruno Amato1,2, Rita Compagna1,2, Maurizio Amato2, Lucia Butrico3, Francesco Fugetto4, Mariia D Chibireva5, Andrea Barbetta3, Marco Cannistrà6, Stefano de Franciscis1,3, Raffaele Serra1,3.   

Abstract

Wound healing is an articulated process that can be impaired in different steps in chronic wounds. Chronic leg ulcers are a special type of non-healing wounds that represent an important cause of morbidity and public cost in western countries. Because of their common recurrence after conventional managements and increasing prevalence due to an ageing population, newer approaches are needed. Over the last decade, the research has been focused on innovative treatment strategies, including stem-cell-based therapies. After the initial interest in embryonic pluripotent cells, several different types of adult stem cells have been studied because of ethical issues. Specific types of adult stem cells have shown a high potentiality in tissue healing, in both in vitro and in vivo studies. Aim of this review is to clearly report the newest insights on tissue regeneration medicine, with particular regard for chronic leg ulcers.
© 2015 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Adult tissue-derived stem cells; Chronic leg ulcers; Stem cells; Wound healing

Mesh:

Year:  2015        PMID: 26399452      PMCID: PMC7949523          DOI: 10.1111/iwj.12499

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  126 in total

Review 1.  Principles and practices for treatment of cutaneous wounds with cultured skin substitutes.

Authors:  Steven T Boyce; Glenn D Warden
Journal:  Am J Surg       Date:  2002-04       Impact factor: 2.565

Review 2.  Regulation of wound healing by growth factors and cytokines.

Authors:  Sabine Werner; Richard Grose
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

3.  The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells.

Authors:  Guangwu Xu; Yingyu Zhang; Liying Zhang; Guangwen Ren; Yufang Shi
Journal:  Biochem Biophys Res Commun       Date:  2007-07-20       Impact factor: 3.575

4.  Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries.

Authors:  E Mansilla; G H Marin; F Sturla; H E Drago; M A Gil; E Salas; M C Gardiner; G Piccinelli; S Bossi; E Salas; L Petrelli; G Iorio; C A Ramos; C Soratti
Journal:  Transplant Proc       Date:  2005 Jan-Feb       Impact factor: 1.066

5.  Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls.

Authors:  Miriam A M Loot; Susan B Kenter; Fung L Au; W J M van Galen; Esther Middelkoop; Jan D Bos; Jan R Mekkes
Journal:  Eur J Cell Biol       Date:  2002-03       Impact factor: 4.492

6.  Human embryonic stem cell lines derived from single blastomeres.

Authors:  Irina Klimanskaya; Young Chung; Sandy Becker; Shi-Jiang Lu; Robert Lanza
Journal:  Nature       Date:  2006-08-23       Impact factor: 49.962

7.  Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment.

Authors:  Fernando Anjos-Afonso; Dominique Bonnet
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

8.  Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers.

Authors:  Liliana J Saap; Kevin Donohue; Vincent Falanga
Journal:  Dermatol Surg       Date:  2004-08       Impact factor: 3.398

9.  All-trans-retinoic acid suppresses matrix metalloproteinase activity and increases collagen synthesis in diabetic human skin in organ culture.

Authors:  Humaira Lateef; Martin J Stevens; James Varani
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

10.  Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.

Authors:  M Shah; D M Foreman; M W Ferguson
Journal:  J Cell Sci       Date:  1995-03       Impact factor: 5.285

View more
  3 in total

1.  CGF Treatment of Leg Ulcers: a Randomized Controlled Trial.

Authors:  Bruno Amato; Michele Angelo Farina; Silvana Campisi; Marino Ciliberti; Vincenzo Di Donna; Anna Florio; Antonino Grasso; Rosario Miranda; Francesco Pompeo; Eleonora Farina; Raffaele Serra; Roberto Cirocchi; Francesca Calemma; Aldo Rocca; Rita Compagna
Journal:  Open Med (Wars)       Date:  2019-12-24

2.  MSC-Derived Extracellular Vesicles to Heal Diabetic Wounds: a Systematic Review and Meta-Analysis of Preclinical Animal Studies.

Authors:  Adrian J M Bailey; Heidi Li; Aidan M Kirkham; Alvin Tieu; Harinad B Maganti; Risa Shorr; Dean A Fergusson; Manoj M Lalu; Heidi Elomazzen; David S Allan
Journal:  Stem Cell Rev Rep       Date:  2021-04-24       Impact factor: 6.692

3.  Adipose-derived stem cells for treatment of chronic ulcers: current status.

Authors:  Jens Selch Holm; Navid Mohamadpour Toyserkani; Jens Ahm Sorensen
Journal:  Stem Cell Res Ther       Date:  2018-05-15       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.